The University of Southampton
University of Southampton Institutional Repository

Nimodipine for subarachnoid haemorrhage: the end of the road or better trials?

Nimodipine for subarachnoid haemorrhage: the end of the road or better trials?
Nimodipine for subarachnoid haemorrhage: the end of the road or better trials?
Traumatic subarachnoid haemorrhage is a common finding in all degrees of severity of head injury and is an independent predictor of poor outcome. However, to what extent the presence of subarachnoid blood contributes to secondary deterioration or whether this is simply an epiphenomenon of the injury is unclear. In patients with aneurysmal subarachnoid haemorrhage nimodipine is widely used for the prevention and treatment of cerebral vasospasm, a major contributor to morbidity and mortality in this disorder. Although the main effect of nimodipine is thought to be relaxation of the smooth muscle of the cerebral vasculature mediated by its Ca2+ antagonistic action, other mechanisms have been invoked, including possible antioxidant activity
trial
1474-4422
993-994
Sen, Jon
464edd7f-7891-4e3f-a86c-0675fd129828
Belli, Antonio
33707b7b-b004-4245-aead-98a8e1e2b2e2
Sen, Jon
464edd7f-7891-4e3f-a86c-0675fd129828
Belli, Antonio
33707b7b-b004-4245-aead-98a8e1e2b2e2

Sen, Jon and Belli, Antonio (2006) Nimodipine for subarachnoid haemorrhage: the end of the road or better trials? The Lancet Neurology, 5 (12), 993-994. (doi:10.1016/S1474-4422(06)70583-X).

Record type: Article

Abstract

Traumatic subarachnoid haemorrhage is a common finding in all degrees of severity of head injury and is an independent predictor of poor outcome. However, to what extent the presence of subarachnoid blood contributes to secondary deterioration or whether this is simply an epiphenomenon of the injury is unclear. In patients with aneurysmal subarachnoid haemorrhage nimodipine is widely used for the prevention and treatment of cerebral vasospasm, a major contributor to morbidity and mortality in this disorder. Although the main effect of nimodipine is thought to be relaxation of the smooth muscle of the cerebral vasculature mediated by its Ca2+ antagonistic action, other mechanisms have been invoked, including possible antioxidant activity

This record has no associated files available for download.

More information

Published date: 2006
Keywords: trial

Identifiers

Local EPrints ID: 62576
URI: http://eprints.soton.ac.uk/id/eprint/62576
ISSN: 1474-4422
PURE UUID: 97a88453-6e27-4fb7-9784-f482a57ed641

Catalogue record

Date deposited: 05 Sep 2008
Last modified: 15 Mar 2024 11:31

Export record

Altmetrics

Contributors

Author: Jon Sen
Author: Antonio Belli

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×